Is Allurion Technologies Inc. (ALUR) a Buy, Sell, or Hold?
OTC : ALUR
Allurion Technologies Inc.
$4.715 USD
-$0.79 (-14.27%)
- Volume
- 2.28K
- Average Volume
- 4.59K
- Market Capitalization
- $4.72M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $49.95
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.30
| Source | Headline |
|---|---|
|
Allurion Advances Plan to Re-List
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced a 1-for-15 reverse stock of its outstanding common stock intended to support regaining compliance with the continued listing requirements of the New York Stock Exchange (the “NYSE”) or initial listing requirements of the NYSE American. Allurion continues to actively engage with national exchanges and is advancing its re-listing strategy as part of a comprehe. businesswire.com - 2026-06-17 16:05:00 |
|
Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced successful early traction in the launch of the Allurion Program in the United States, marked by strong clinical outcomes, rapid account growth, high re-order rates, and performance exceeding internal expectations. First shipments of the Allurion Smart Capsule were completed in April, with the first U.S. patients treated that same month. Early clinical outcom. businesswire.com - 2026-06-02 09:00:00 |
